Bill · S. 664· Senate(119-S-664)
NIH Reform Act
- Introduced
- 2/20/2025
- Last activity
- 2/20/2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsored by
- Rand Paul
- Cosponsors
- - 1 - 0
- Introduced
- In Committee
What this bill would do
The NIH Reform Act proposes to replace the National Institute of Allergy and Infectious Diseases with three distinct national research institutes. These new entities would be the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill establishes specific purposes for the two new institutes regarding research, training, and health information. It also mandates that the President appoint directors for these institutes with the advice and consent of the Senate. These directors would serve five-year terms and are eligible for one additional term.
Yes
Does this make health care easier to get in general?+2
The bill reorganizes NIH institutes to provide more specialized focus on infectious and immunologic diseases.
Does this put more money into medical research?+2
The bill restructures the organization of research into three specialized institutes to support research, training, and information dissemination.
Does this make what the government does easier for the public to see?+1
The bill formalizes the appointment process and term limits for the directors of the new specialized institutes.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Clearer Focus for Research: The bill establishes specific purposes for the new institutes, such as the National Institute of Infectious Diseases focusing on research and training for infectious diseases, including tropical diseases (Section 2(c)(1)(A) and Section 2(c)(2)(A)).
-
Specialized Research Oversight: The creation of the National Institute of Immunologic Diseases provides a dedicated entity for the conduct and support of research and programs regarding immunologic diseases and disorders (Section 2(c)(3)(A)).
Potential Negative Impacts for People
- Organizational Transition Period: During the transition period following the termination of the National Institute of Allergy and Infectious Diseases, the new institutes will be overseen by the Director of the National Institutes of Health until individual directors are appointed (Section 2(b)(3)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Healthcare Access+2Increases Research Funding+2
- Governance And Ideology
- Improves Government Transparency+1
- 2/20/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Tommy TubervilleRepublican · Alabama